Category Archives: Stem Cell Treatment


Stem cell therapy | Stem cell treatment | Unique Cell …

Prof. Alexander Smikodub

MD Ph.D

Alexander Smikodub jr.

MD Ph.D

Our clinic offers the advanced and patented methods of fetal stem cell treatment for various conditions and diseases. This method of treatment can be found in wikipedia: Stem cell therapy. Fetal stem cells are non-specialized cells that differentiate (turn) into any other cell type of the body that form organs and tissues. Fetal stem cells that we use for treatment have huge potential for growth, differentiation and are not rejected by the patients body, which allows to achieve unique long-term clinical effects.

We have more than 15 years of experience in stem cell therapy and are the leaders of the industry. Most of the methodic used in the clinic are unique and patent protected in many countries including USA. Since 1994 prof. Alexander Smikodub Sr. was the main researcher, doctor and administrator of the clinic. Now his son, Alexander Smikodub Jr. M.D. continues his fathers venture. During these years more than 6500 patients from all over the world received fetal stem cell treatment, resulting in significant improvement of their conditions, and in case of timely contact with us in complete cure of the diseases still considered lethal by most medical institutions.

Read more...

Stem cells are the new word in the medical science, possibly the new revolution. Their importance can be compared with antibiotics discovery or the first successful heart transplantation. They are the inner restorative and regenerative reserve of your body, found in blood, fat layer and bone marrow. After injection of a big stem cells doze, impaired tissues are recovered, regeneration speed is increased and overall condition is greatly improved. We use only material from healthy patients, which passes multiple security checks. They are a perfect material for treating a wide variety of neural and physical diseases.

Read the original:
Stem cell therapy | Stem cell treatment | Unique Cell ...

Stem cell-based treatment for baldness a step closer

As one of the follically-challenged, any new breakthroughs in the area of hair regeneration will generally get my attention. When stem cells first started to gain widespread media attention I, no doubt like many others, thought a full head of hair was just around the corner. But despite numerous developments, years later my dome is still of the chrome variety. Providing the latest cause for cautious optimism, researchers have now developed a way to generate a large number number of hair-follicle-generating stem cells from adult cells.

In what they claim is a world first, researchers from the University of Pennsylvania (UPenn) and the New Jersey Institute of Technology have developed a technique to convert adult human stem cells into epithelial stem cells (EpSCs).

By adding three genes to human skin cells called dermal fibroblasts that live in the dermis layer of the skin and generate connective tissue, a team led by Xiaowei "George" Xu, MD, PhD, at the Perelman School of Medicine was able to convert them into induced pluripotent stem cells (iPSCs). The iPSCs, which have the ability to differentiate into any cell type, were then converted into epithelial stem cells (EpSCs) that are normally found at the bulge of hair follicles.

Through careful control of the timing of delivery of growth factors to the cells, the researchers say they were able to turn over 25 percent of the iPSCs into EpSCs in 18 days. When they then mixed these EpSCs with mouse follicular inductive dermal cells and grafted them onto the skin of immunodeficient mice, functional human epidermis and follicles similar to hair follicles were produced.

"This is the first time anyone has made scalable amounts of epithelial stem cells that are capable of generating the epithelial component of hair follicles, said Xu, who added that these cells have many potential applications, including wound healing, cosmetics, and hair regeneration.

But some hurdles still need to be jumped before I make my first trip to the hairdresser in a decade. Xu points out that when a person loses hair, they lose not only epithelial cells, but also a kind of adult stem cell called dermal papillae. "We have solved one major problem, the epithelial component of the hair follicle. We need to figure out a way to also make new dermal papillae cells, and no one has figured that part out yet."

On a positive note, researchers from the Tokyo University of Science have reported promising results in reconstructing hair follicle germs from adult epithelial stem cells and cultured dermal papilla cells, so even though we haven't rounded the corner yet,it definitely seems to be getting closer.

The teams research is published in the journal Nature Communications.

Source: University of Pennsylvania

Go here to see the original:
Stem cell-based treatment for baldness a step closer

Stem cell treatment: Controversial for humans, but not for pets

PHOENIX, Ariz. -

Stem cell research and therapy on humans has traveled a long and often politically troubled path.

Not so for pets, where stem cell treatment has been used for nearly 10 years and now it is so routine, and so successful, it can be done in a day.

Ava is a 90 pound, 2-year-old Akita, who is about to undergo stem cell surgery. A little IV, a little anesthesia and Ava is out.

"It is used for arthritis mostly," said Dr. Velvet Edwards.

Ava is just beginning her day at Pecan Grove Veterinary Hospital in Tempe. Dr. Edwards oversees the stem cell procedure.

"Stem cells are healing cells, so they seek out area of injury damage or destruction," explained Edwards. "They accelerate healing and help the animal, the patient, the pet just use their own natural abilities to get better."

Veterinary stem cells are harvested from the animal's own fat cells. They are separated and processed by machinery right inside the vet's office and then injected back into the dog's trouble spots.

Thanks to new technology developed by Meti Vet, the process is completed in just a day.

"The pet comes in the morning, it's anesthetized and I collect about two to four grams of fat usually behind the shoulder blade," said Edwards. "Then I hand that fat over to my technicians to run it through a series of steps.. basically to dissolve the fat and get down to a little stem cell pellet... Then we take that pellet and we reconstitute it and make it injectable. I will put it back into the animal's body wherever I need it later that day."

More here:
Stem cell treatment: Controversial for humans, but not for pets

Chemical stem cell signature predicts treatment response for acute myeloid leukemia

PUBLIC RELEASE DATE:

3-Feb-2014

Contact: Kim Newman sciencenews@einstein.yu.edu 718-430-3101 Albert Einstein College of Medicine

February 3, 2014 (Bronx, NY) Researchers at Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have found a chemical "signature" in blood-forming stem cells that predicts whether patients with acute myeloid leukemia (AML) will respond to chemotherapy.

The findings are based on data from nearly 700 AML patients. If validated in clinical trials, the signature would help physicians better identify which AML patients would benefit from chemotherapy and which patients have a prognosis so grave that they may be candidates for more aggressive treatments such as bone-marrow transplantation. The paper was published today in the online edition of the Journal of Clinical Investigation.

Sparing Patients from Debilitating Side Effects

According to the American Cancer Society, AML accounts for nearly one-third of all new leukemia cases each year. In 2013, more than 10,000 patients died of AML.

"AML is a disease in which fewer than 30 percent of patients are cured," said co-senior author Ulrich Steidl, M.D., Ph.D., associate professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Einstein and associate chair for translational research in oncology at Montefiore. "Ideally, we would like to increase that cure rate. But in the meantime, it would help if we could identify who won't benefit from standard treatment, so we can spare them the debilitating effects of chemotherapy and get them into clinical trials for experimental therapies that might be more effective."

Analyzing Methylation Patterns

The Einstein study focused on so-called epigenetic "marks" chemical changes in DNA that turn genes on or off. The researchers focused on one common epigenetic process known as methylation, in which methyl (CH3) groups attach in various patterns to the genes of human cells. Researchers have known that aberrations in the methylation of hematopoietic, or blood-forming, stem cells (HSCs) can prevent them from differentiating into mature blood cells, leading to AML.

View post:
Chemical stem cell signature predicts treatment response for acute myeloid leukemia

iPSC Induced Pluripotent Stem Cell Market 2013 14 Complete Report at ReportsnReports.com

Dallas, Texas (PRWEB) February 02, 2014

Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their unspecialized nature allows them to differentiate into a wide variety of specialized cell types. The possibilities arising from these characteristics have caused great commercial interest, with potential applications ranging from the use of stem cells in reversal or treatment of disease, to targeted cell therapy, tissue regeneration, pharmacological testing on cell-specific tissues, and more. Diseases such as Huntingtons Chorea, Parkinsons Disease, and spinal cord injuries are examples of clinical applications in which stem cells could offer benefits in halting or even reversing damage.

Traditionally, scientists have worked with both embryonic and adult stem cells as research tools. While the appeal of embryonic cells has been their ability to differentiate into any type of cell, there has been significant ethical, moral and spiritual controversy surrounding their use for research purposes. Although some adult stem cells do have differentiation capacity, it is often limited in nature, which creates narrow options for use. Thus, induced pluripotent stem cells sector (http://www.reportsnreports.com/reports/206575-complete-2012-13-induced-pluripotent-stem-cell-industry-report.html) represent a promising combination of adult and embryonic stem cell characteristics.

Continued research and experimentation has resulted in numerous advances over the last few years. In one example, the University of Michigan announced in Circulation Research (2012) that they had developed innovative methods for use of induced pluripotent stem cells derived from skin biopsies to create cardiac muscle cells. This accomplishment quickly fueled other research into the use of iPSCs for the reversal and repair of diseased heart tissue.

Similar advances will continue to be perfected for use of reprogrammed adult cells in the treatment of other diseases and disorders. Original techniques for iPSC production, such as viral induced transcription processes, are being replaced with newer technologies as private industries join with the scientific community to develop safe and efficient methods of iPSC production. With sustained research and experimentation, established guidelines for effective production of iPSCs will be commonplace.

In summary, induced pluripotent stem cells represent a promising tool for use in the reversal and repair of many previously incurable diseases.

Market Metrics - iPSC Research Products: For this reason a large and thriving research products market has grown into existence for the cell type. The number of iPSC research products sold worldwide has been growing at an annual rate of 14.7% for the past five years. In addition, 22% of all stem cell researchers now self-report as having used induced pluripotent stem cells within a research project. It is clear that iPSCs are a vital research trend within the scientific community.

A distinctive feature of this report is an end-user survey of 274 researchers (131 U.S. / 143 International) that identify as having induced pluripotent stem cells as their core research focus. These survey findings reveal iPSC researcher needs, technical preferences, key factors influencing buying decisions, and more. They can be used to make effective product development decisions, create targeted marketing messages, and produce higher prospect-to-client conversion rates.

Remember, to benefit from this lucrative product market, you need to anticipate and serve the needs of your clients, or your competitors will.

Purchase Report @ http://www.reportsnreports.com/purchase.aspx?name=206575.

Originally posted here:
iPSC Induced Pluripotent Stem Cell Market 2013 14 Complete Report at ReportsnReports.com

Parkinsons sufferer has vital treatment

Parkinson's Disease sufferer James DeLittle has vital treatment in Kiev

9:57am Monday 3rd February 2014 in News By Mike Laycock, Chief reporter

A PARKINSONS Disease sufferer has returned home to York after pioneering stem cell treatment in Kiev and he already appears to be feeling the benefits.

James DeLittle, 49, of Broadway West in Fulford, is enjoying improved balance, which reduces the risks of falling over, said his mother Rosemary.

But she said the clinic that provided the two-day treatment had said it could be up to five months before the full effects were known.

The Press reported earlier this month that James condition had worsened significantly in recent months, affecting his balance and causing him to fall several times, suffering injuries including a broken nose, ribs and thumb joint.

He decided to travel to a clinic in the Ukrainian capital Kiev for foetal stem cells to be injected into him in a bid to tackle the illness.

The clinic told him it had treated more than 100 patients with Parkinsons in recent years, with improvements reported in 75 per cent of cases, including reduction of tremor and rigidity, and cognitive and gait improvements.

The former St Peters School pupil said he believed he was the first person from the UK to go to the clinic, but it was costing 7,000 to pay for the treatment, travel and accommodation.

After the article appeared, his family received donations from well-wishers who wanted to help with the costs.

Read more here:
Parkinsons sufferer has vital treatment

Work With A Quality Doctor At The Mississippi Stem Cell Treatment Center – Video


Work With A Quality Doctor At The Mississippi Stem Cell Treatment Center
Every doctor at the Mississippi Stem Cell Treatment Center is dedicated to stem cell research and advancement. Visit us at 1153 Ocean Springs Rd., Ocean Spri...

By: Mississippi Stem Cell Treatment Center

Read more from the original source:
Work With A Quality Doctor At The Mississippi Stem Cell Treatment Center - Video

Stem Cell Treatment Analytical Stem Cell

The Truth About Adult Stem Cell Treatment

Ask about opportunities to participate in clinical trials at US centers in Florida, Colorado, Indiana, Nebraska and Atlanta. We are currently recruiting patients with diabetes, COPD, osteoarthritis, critical limb ischemia, and erectile dysfunction protocols using adipose derived stem cells. Contact 1-480-243-8859 or email info@stemcelltreatment.org to learn more about inclusion and exclusion criteria in these studies.

Update: Analytical Stem Cellis now offering culture expansion and cryo-storage of mesenchymal stem cells from adipose (fat) tissue. Your fat tissue can be sent to Bioheart Labs in Florida for expansion. Millions of cells can be grown and then frozen at extremely cold temperatures in liquid nitrogen. A lifetime supply of cells are available for future use as you need them.

The discovery of adult stem cell therapy has been a medical breakthrough because society has discovered how effective this method is in assisting a number of diseases. Adult stem cells are derived from a number of biological sources such as: blood, umbilical cords, bone marrow, muscle, placenta, fat, breast milk, dental pulp, and other sources. It has been found that these adult stem cells act as the bodys natural healing cells which are why they are used to heal a number of diseases that modern medicine is unable to remedy.

The best part about using adult stem cells is that there are virtually zero side effects. It has been used for over 40 years in the treatment of cancer, and research has shown that it has also been effective in the treatment of over 130 other diseases such as multiple sclerosis, autism, diabetes, and many other diseases and ailments.

Stem cells are a type of cell that can potentially develop into a variety of cell types within the body, depending if they fall into the category of either pluripotent or multipotent stem cells. There is a significant difference in these types of cells: the first one can grow into almost any other kind of cell within the body except the type of cell which is needed to support a fetus.

They can also develop into multipotent cells which serve as a type of repair system because as long as the host is alive, these types of stem cells can divide infinitely as long as required to repair and replenish other cells. Once a stem cell has divided, it may either remain as is but it also has the ability to become another type of cell.

Stem cells are effective in treating disease because of their unique ability in developing support to other cells in the body. They also work in our bodys tissues to repair any cells that need it. Apart from just curing disease, stem cell treatments have been effective in pain management as well as prevention. This makes stem cell treatment the most ideal and safe medical treatment which everyone should consider using.

The stem cell treatments doctors provide, allow your stem cells to aid in the regeneration of cells as well as specific organs which may be affected by degeneration, disease, or disorder. The stem cells also have the powerful ability of detecting damaged tissues, and targeting those tissues directly to help them repair, which can provide considerable improvement and benefit to a persons medical condition where other types of therapies fail to work.

Should You Consider Treatment With Stem Cells?

Read more here:
Stem Cell Treatment Analytical Stem Cell